德國(guó)Fresenius Biotech www.fresenius-biotech.com
費(fèi)森尤斯生物技術(shù)：生物制藥產(chǎn)品的開(kāi)發(fā)及銷售，主要應(yīng)用于基因、腫瘤、移植和再生醫(yī)學(xué)領(lǐng)域。 

Fresenius Biotech is dedicated to delivering innovative therapeutics to patients with serious illnesses that have a high degree of unmet need. A focal point of our activities is the development of immunotherapeutic products based on innovative antibody technologies. Our focused approach to research and development combined with our international marketing experience enables us to efficiently bring targeted therapeutics to a global patient population.
Our main areas of research:
Transplantation 
Oncology 
Our core competencies:
Preclinical research and clinical development 
Worldwide registration of biopharmaceuticals 
Innovative marketing for specialized indications 
Attaining market access for innovative products 
Founded in 2003, Fresenius Biotech employs approx. 170 employees in Europe and the USA. Fresenius Biotech is a subsidiary of the Fresenius SE healthcare group.